(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 7.92% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.02%.
Albemarle's revenue in 2026 is $5,494,583,000.On average, 24 Wall Street analysts forecast ALB's revenue for 2026 to be $751,951,334,776, with the lowest ALB revenue forecast at $660,316,110,949, and the highest ALB revenue forecast at $916,352,238,270. On average, 22 Wall Street analysts forecast ALB's revenue for 2027 to be $768,108,381,963, with the lowest ALB revenue forecast at $595,923,791,503, and the highest ALB revenue forecast at $1,009,756,481,862.
In 2028, ALB is forecast to generate $823,537,667,933 in revenue, with the lowest revenue forecast at $587,196,627,329 and the highest revenue forecast at $1,113,185,170,789.